Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity
Bryan A. Ward, J. Christopher Gorski, David R. Jones, Stephen D. Hall, David A. Flockhart and Zeruesenay Desta
Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 287-300; DOI: https://doi.org/10.1124/jpet.103.049601
Bryan A. Ward
J. Christopher Gorski
David R. Jones
Stephen D. Hall
David A. Flockhart

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 306, Issue 1
1 Jul 2003
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity
Bryan A. Ward, J. Christopher Gorski, David R. Jones, Stephen D. Hall, David A. Flockhart and Zeruesenay Desta
Journal of Pharmacology and Experimental Therapeutics July 1, 2003, 306 (1) 287-300; DOI: https://doi.org/10.1124/jpet.103.049601
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity
Bryan A. Ward, J. Christopher Gorski, David R. Jones, Stephen D. Hall, David A. Flockhart and Zeruesenay Desta
Journal of Pharmacology and Experimental Therapeutics July 1, 2003, 306 (1) 287-300; DOI: https://doi.org/10.1124/jpet.103.049601